Use of tyrosine kinase inhibitor to treat diabetes

Details Use of tyrosine kinase inhibitor to treat diabetes Use of tyrosine kinase inhibitor to treat diabetes

2011-01-25

2011-01-25

Weddington, Kevin (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S252140, C514S269000, C514S272000, C514S866000

Reexamination Certificate

active

07875616

ABSTRACT:
The invention relates to the use of a c-Abl-, PDGF-R-, or c-kit- tyrosine kinase inhibitor, e.g. 4-(4-methylpiperazin-1 -ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide, or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of diabetes, e.g. type I diabetes, type II diabetes.

REFERENCES:
patent: 6194454 (2001-02-01), Dow
patent: 7087608 (2006-08-01), Atkins et al.
patent: 2002/0022646 (2002-02-01), Avrutov et al.
patent: 2002/0035140 (2002-03-01), Moon et al.
patent: 564409 (1993-10-01), None
patent: WO 9903854 (1999-01-01), None
patent: 99/10325 (1999-03-01), None
patent: 01/64200 (2001-09-01), None
patent: WO 01/64200 (2001-09-01), None
patent: 02/055517 (2002-07-01), None
patent: 03/020698 (2003-03-01), None
patent: 03/097110 (2003-11-01), None
patent: WO 03/097110 (2003-11-01), None
patent: 2004/015082 (2004-02-01), None
patent: 2004/043408 (2004-05-01), None
Veneri et al., “Imatinib and Regression of Type 2 Diabetes”, The New England Journal of Medicine, vol. 352, No. 10, pp. 1049-1050 (Mar. 10, 2005).
Lassila et al., “Imatinib attenuates diabetes-associated atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24(5), pp. 935-942, (May 2004).
Dumas J., “Protein kinase inhibitors: emerging pharmacophores 1997-2000,” Expert Opinion on Therapeutic Patents, Ashley Publications, GB, vol. 11(3) pp. 405-429 (2001).

Affiliated with

Also associated with

Rating

Use of tyrosine kinase inhibitor to treat diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of tyrosine kinase inhibitor to treat diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of tyrosine kinase inhibitor to treat diabetes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2641008